Chief Development Officer

This is a fully remote position, open to applicants in United States.

📋 Description

• Responsible for the clinical development strategy across the LTx portfolio, ensuring that each asset achieves a value-generating Phase 2 proof-of-concept readout swiftly and in a capital-efficient manner.

• Participate as a voting member on Lindus’ investment committee (alongside the CEO and CMO), making decisions on which assets to in-license and develop.

• Create designs for Phase 1 and Phase 2 studies, which include first-in-human (FIH) and dose-escalation strategies, endpoints, patient demographics, biomarker methodologies, and go/no-go criteria.

• Oversee scientific and clinical due diligence on shortlisted assets in collaboration with the deal team and external experts, making critical decisions regarding their developability.

• Establish and lead a virtual development organization, recruiting and managing fractional and consulting experts in CMC, regulatory affairs, pharmacology, and clinical operations.

• Design each program with an exit strategy in mind, ensuring that the Phase 2 clinical and CMC packages are tailored to meet the expectations of strategic or specialty pharma buyers.

• Collaborate with the VP of Corporate Development on asset assessments, deal structuring, and negotiations, providing insights from a development perspective during due diligence.

• Direct regulatory communications with the FDA, EMA, and other regulatory bodies, including pre-IND meetings, Type B interactions, and scientific advisory processes.

• Advocate for LTx's development strategy to investors, partners, and the board.

⛳️ Requirements

• A senior leader in clinical development with experience leading clinical programs through Phase 1 and Phase 2 in pharmaceutical or biotech firms across multiple non-oncology therapeutic domains.

• Familiarity with in-licensed and partnered assets.

• Ability to design strategies with an exit in mind.

• Portfolio management experience, having managed or overseen several programs simultaneously and comfortable making tough prioritization decisions between assets.

• Proven ability to operate efficiently in a biotech environment, delivering robust Phase 1 and Phase 2 data under tight constraints.

• An established network to utilize, capable of building regulatory, CMC, pharmacology, and clinical capabilities as needed by each asset.

• Proficient with AI tools, applying them in research, planning, and analysis, with a clear understanding of their utility versus the need for scientific judgment.

🏝️ Benefits

• Competitive salary plus significant equity; you'll have ownership in what we are building.

• $2,000 annual budget for Learning & Development, applicable for courses, certifications, and conferences.

• $800 monthly employer contribution for insurance for US team members (via TriNet PEO).

• $40 monthly wellness allowance with flexible spending options, including company private health insurance or a Wellhub membership.

• Access to gym and retail discounts through Happl.

• Regular company events and team gatherings, both virtual and in-person.

• Charity partnerships and volunteering opportunities with Forward Trust.

• Collaborate with a team dedicated to improving healthcare for the better.